Process And Product Innovation: The Enabling Process Of Managing Regulatory Compliance

1045 Words 4 Pages
Process & Product Innovation One way or another companies are always trying to improve whether it be their quality, speed to market, spending or manufacturing. This goes without saying that, as always, the consumer and the consumer’s consumer (in this case the patient) is the number one focus. Regardless of what these companies want to do or change to their process and their products there will always be obstacles. Major examples of these obstacles are, fear of there being too few trainers for these complex products, maintenance/purchasing of spare parts, and ability to identify problems (Barriers to Innovation, 11). Johnson & Johnson’s current production processes they are testing out is what they are calling, “continuous manufacturing.” …show more content…
“By optimizing supply chains, implementing strategies to reduce inventory and streamlining transportation and deliveries, 3PLs alleviate the pain that comes with supply chain transformation and help relieve some of their customers’ financial pressures” (Buxbaum, 1). This is in full efforts to fulfill or ease any of the regulatory concerns including making flexible storage and fulfillment arrangements, which connects directly to the Enabling Process of Managing Regulatory Compliance (sE8). Breaking it down though shows the requirement of fulfilling earlier Enabling Processes including Managing Supply Chain Contract (sE6) and Managing Supply Chain Configurations …show more content…
Obviously this is just as, if not more, important in the medical device industry since it is lives these companies are dealing with. A top three company like Johnson & Johnson calls this goal their triple aim; improving patient outcome, increasing patient satisfaction and reducing costs (2014 Citizenship, 19). Gary Pruden the Worldwide Chairman of Johnson & Johnson Medical Devices stated, “The bold steps we are taking today are to evolve our offerings, structure and footprint and increase our investment in innovation. These actions recognize the changing needs of the global medical device market and will deliver more value to customers, increasing our competitive advantage and driving growth and profitability for our business." With their high number of businesses who help them supply their devices, J&J works specifically with the processes of Deliver Make-to-Order & Engineer-to-Order Product since they are making such specific and specialized products for their customers. The plan involves savings of as little as $800 million and as much as $1 billion by the end of 2018. “The savings will provide the company with added flexibility and resources to fund investment in new growth opportunities and innovative solutions for customers and patients” (Johnson & Johnson,

Related Documents